SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-20-000313
Filing Date
2020-07-02
Accepted
2020-07-02 09:17:47
Documents
2
Effectiveness Date
2020-07-02

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1094
2 ptla-form25.txt EX-99.25 103
  Complete submission text file 0001354457-20-000313.txt   2842
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Subject) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-35935 | Film No.: 201007386
SIC: 2834 Pharmaceutical Preparations

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
The Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE